Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

DUKE UNIVERSITY

Parent9 subsidiariesUEI: TP7EK8DZV6N5CAGE: 4B478

DUKE UNIVERSITY is a federal contractor, registered under UEI TP7EK8DZV6N5 and CAGE code 4B478. It has been awarded $13,591,125,000 in federal contracts. Primary work spans Unknown NAICS, Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology), and Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology). Top awarding agencies include Department Of Health And Human Services, Department Of Defense, and National Science Foundation.

Contact Information

Registration and classification details

Registration

UEI Code

TP7EK8DZV6N5

CAGE Code

4B478

Entity Structure

Corporate Entity (Tax Exempt)

Established

N/A

Business Classifications

Educational InstitutionNon-Profit OrganizationPrivate University or College

NAICS Codes

541611Administrative Management and General Management Consulting Services
541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
611310Colleges, Universities, and Professional Schools(Primary)
611430Professional and Management Development Training

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Duke University specializes in advanced research and development across the physical, engineering, and life sciences, with deep expertise in biomedical innovation, clinical trial design, and translational science. The contractor delivers high-complexity R&D services including pediatric pharmaceutica...

Duke University specializes in advanced research and development across the physical, engineering, and life sciences, with deep expertise in biomedical innovation, clinical trial design, and translational science. The contractor delivers high-complexity R&D services including pediatric pharmaceutical trials, nonhuman primate immunology research, and bioengineering solutions for defense and public health applications. Technical capabilities span protocol development, informed consent framework design, laboratory operations for infectious disease and vaccine research, and specialized testing services supporting military and civilian health initiatives. A distinguishing strength lies in integrating academic rigor with mission-critical government requirements, particularly in immunology, virology, and therapeutic development pipelines. The institution maintains sustained partnerships with the Department of Health and Human Services, where it leads pediatric clinical research networks and immunology core laboratories for AIDS vaccine development. It also supports the Department of Defense through biotechnology research, laboratory testing, and educational programs for military personnel, including ROTC tuition and leadership training. Additional engagements with the Department of Veterans Affairs and the Environmental Protection Agency reflect a broad footprint in health science and environmental research. Primary industry focus centers on R&D in life sciences (NAICS 541715 and 541714), with significant activity in biological and biomedical innovation, supported by testing laboratories and educational administration services. The contractor is uniquely positioned as a university-based research engine serving federal health, defense, and science missions through evidence-based, peer-reviewed methodologies and scalable infrastructure. As a non-profit academic institution headquartered in Durham, North Carolina, Duke University operates under its institutional charter with no federal business certifications. Its government market presence is anchored in federally funded research and education programs, leveraging its campus-based laboratories, clinical facilities, and multidisciplinary research teams to deliver mission-aligned scientific outcomes.

Key Performance Metrics

Awards Count

12,771

All time

Active

1,426

Currently performing

Completed

11,345

Past period of performance

Total Awards

All time

Award Analytics & Distribution

Awards by Agency
Awards by Agency Over Time
Awards by Place of Performance

Compete with DUKE UNIVERSITY

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for DUKE UNIVERSITY

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in DUKE UNIVERSITY's top NAICS codes and agencies

NAICS: 541715
New
Federal
Common Autonomous Multi-Domain Launcher (CAML)-Lite Prototype Effort
Solicitation # W50RAJ27CAML_LITE
The Common Autonomous Multi-Domain Launcher (CAML)-Lite Prototype Effort is a competitive procurement conducted under 10 U.S.C. section 4022 Other Transaction Authority to develop a mobile, optionally manned, autonomous launcher for cross-domain offensive and defensive fires. The program is structured in two phases, beginning with Phase 1, which requires a prototype demonstration at Talisman Sabre 2027 in August 2027. This initial phase includes a priced option for the acquisition of additional prototype units, New Equipment Training, and Contractor Logistics Support. Phase 2 focuses on prototype maturation and integration into a common CAML architecture. The government seeks solutions that utilize a Modular Open Systems Approach to ensure interchangeable modules and autonomous munition resupply with minimal human intervention. The procurement process begins with the submission of a Solutions Brief, with a deadline of October 26, 2026. The government will evaluate these briefs based on technical soundness, credibility in addressing objectives, and the feasibility of the maturation path to select the most meritorious respondents for a subsequent Request for Prototype Proposal. Award for Phase 1 is expected by December 18, 2026. Selected performers must assume full responsibility for international logistics and compliance for transporting systems to Australia. Funding for the demonstration will be provided at initial award, though performer investment is required and may positively influence selection. Final acceptance of the effort is contingent upon successful performance verification, cybersecurity Authority to Operate, and government approval of the Technical Data Package.
W6DV Peo M & S Redstone

POSTED

2 days ago

DEADLINE

in 1 day
View Details